
Avanos Medical, Inc.
- Jurisdiction
United States - LEI
549300YCXWOM7NEWMQ58 - ISIN
US05350V1061 (AVNS )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Read full profile
Fundamentals
- Net revenue
€590.67M - Gross margin
53.8% - EBIT
-€401.48M - EBIT margin
-68.0% - Net income
-€395.09M - Net margin
-66.9%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
BLACKFORD GARY | N/A |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: May 2, 2024 (Q1 2024)